Jane Street
LJPC

Jane Street’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Jane Street’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-35,924
Closed -$154K – 11325
2021
Q2 		$154K Buy
35,924
+24,751
+222% +$106K ﹤0.01% 9035
2021
Q1 		$47K Buy
+11,173
New +$61.6K ﹤0.01% 8855
2019
Q1 		– Sell
-14,218
Closed -$134K – 6146
2018
Q4 		$134K Buy
+14,218
New +$214K ﹤0.01% 4582
2017
Q4 		– Sell
-5,756
Closed -$200K – 5650
2017
Q3 		$200K Buy
+5,756
New +$185K ﹤0.01% 4142
2014
Q2 		– Sell
-20,381
Closed -$220K – 3630
2014
Q1 		$220K Buy
+20,381
New +$200K ﹤0.01% 2287

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Jane Street's LJPC Position: Q3 2021 in Review

Jane Street sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 35,924 shares — an estimated $154K sold.

Jane Street first reported a position in LJPC in Q1 2014 and held it in 5 quarters. The position peaked at $220K in Q1 2014. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Jane Street reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Jane Street sold 35,924 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $154K.
  • Jane Street first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 5 quarters.
  • Jane Street's La Jolla Pharmaceutical Company position peaked at $220K in Q1 2014.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.